SCHEMBL2829008

SCHEMBL2829008

Oc1ccc(C=CC=CC=Cc2ccc(O)cc2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 7/20 1.00
KDM4E B2RXH2 3/20 0.68
ALDH1A1 P00352 3/20 0.68
MAPT P10636 3/20 0.68
CYP2C9 P11712 3/20 0.56
CA12 O43570 3/20 0.56
CA1 P00915 3/20 0.56
CA2 P00918 3/20 0.56
CA3 P07451 3/20 0.56
CA4 P22748 3/20 0.56
CA6 P23280 3/20 0.56
CA5A P35218 3/20 0.56
CA7 P43166 3/20 0.56
CA9 Q16790 3/20 0.56
CA14 Q9ULX7 3/20 0.56
CA5B Q9Y2D0 3/20 0.56
MAOB P27338 3/20 0.56
TYR P14679 3/20 0.56
AKR1B1 P15121 3/20 0.56
CA13 Q8N1Q1 2/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21798645 1.00 APP (1.00) APPKDM4EALDH1A1MAPTCYP2C9
SCHEMBL5179114 0.97 APP (0.94) APPKDM4EALDH1A1MAPTCYP2C9
SCHEMBL11439096 0.97 APP (0.94) APPKDM4EALDH1A1MAPTCYP2C9
SCHEMBL15272541 0.88 ALDH1A1 (0.83) APPKDM4EALDH1A1MAPTCYP2C9
SCHEMBL6194091 0.88 ALDH1A1 (0.83) APPKDM4EALDH1A1MAPTCYP2C9
SCHEMBL3218153 0.88 APP (0.77) APPKDM4EALDH1A1MAPTCYP2C9
SCHEMBL303940 0.87 APP (0.76) APPKDM4EALDH1A1MAPTCYP2C9
SCHEMBL2631908 0.87 APP (0.76) APPKDM4EALDH1A1MAPTCYP2C9
SCHEMBL13359845 0.87 APP (0.76) APPKDM4EALDH1A1MAPTCYP2C9
SCHEMBL2632277 0.85 APP (0.73) APPKDM4EALDH1A1MAPTCYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7858072-B2 Stilbene derivatives and their use for binding and imaging amyloid plaques THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2010-12-28 US disclosed
US-20060269474-A1 Stilbene derivatives and their use for binding and imaging amyloid plaques THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2006-11-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060269474-A1 Stilbene derivatives and their use for binding and imaging amyloid plaques APP, APBA1, PSEN1 APP 1/4885KDM4E 4425/4885ALDH1A1 3258/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.